Introduction {#s1}
============

 

In most outpatients with suspected community acquired pneumonia microbial diagnosis is not mandatory since empiric antibiotic treatment is usually succesful. Clinical features and radiologic findings usually fail to identify the etiologic pathogen. Immunosuppressed patients deserve special attention and invasive procedures are compulsory in order to obtain sputum to make specific diagnosis. Empiric antimicrobial coverage should be tailored to treat the most likely pathogen in accordance to individual patient characteristics.

Case report {#s2}
===========

 

A 79-year-old man presented to the emergency department of the Regional Hospital of Bellinzona, Switzerland with a 2-day history of fever and unproductive cough as well as dyspnea on exertion. Previous history was remarkable for chronic corticosteroid use (10 mg daily of prednisone for eight months to treat polymyalgia rheumatica without giant cell arteritis). He was a non-smoker and did not have pre-existing pulmonary diseases. He had not travelled abroad recently, but was gardening during the last week before hospital admission.

On initial presentation, his temperature was 38.5° C, heart rate was 95 beats/min, blood pressure was 128/64 mmHg and his respiratory rate was 18 breaths/min. Physical examination revealed fine crackles of the left lower lobe whereas other findings were normal. Initial oxygen saturation was 94% while breathing room air. Laboratory values were remarkable for anemia (9.1 g/dL, normal range 14-18 g/dL) elevated C-reactive protein (CRP 373 mg/L, normal \<5 mg/L) and elevated creatinine (141 µmol/L, normal \<106 µmol/L). White blood cell count was 10.1 × 10^9^cell/l with a differential showing 83% neutrophils and 8.5% lymphocytes. Pneumococcal and legionella urinary antigen tests were negative. Cultures of blood showed no growth. Chest radiographs did not show focal consolidations. He initiated antibiotic therapy with intravenous ceftriaxone (2 g/24 h). Thereafter he developed a highly productive cough requiring a cough-assist (CoughAssist CM-3200, Megamed, Cham, Switzerland) to successfully clear the bronchial tree.

Two days later he developed a rapid progressive respiratory failure with an impending hemodynamic instability. A chest radiograph revealed an opacification of the left lung suggesting a nearly complete atelectasis; therefore, he underwent intubation. A bronchoscopy did not detect any endobronchial obstruction and on ultrasonography only a minimal left side pleural effusion was visible.

After obtaining secretions from the left upper and lower lobes with mini lavage for culture antibiotic treatment was changed to intravenous imipenem-cilastatin (500 mg/6 h) plus clarithromycin (500 mg/12 h). Prednisone dosage was increased up to 50 mg daily in order to prevent adrenal insufficiency and reduced to 20 mg/d four days later. He was then transferred to the Intensive Care Unit (ICU) of the regional hospital of Mendrisio, Switzerland due to lack of free beds in Bellinzona. On admission the patient was ventilated on pressure-controlled mode with an fraction of inspired oxygen (FIO~2~) of 80%, a peak airway pressure \<30 cm H~2~O, and a positive end-expiratory pressure (PEEP) between 8-10 cm H~2~O in order to maintain oxygen saturation (SaO~2~) \>92%. The paO~2~/FIO~2~ratio was \<200 mmHg. The hemodynamic was supported with norepinephrine (doses between 10-15 mcg/min). A chest computer tomography revealed an airspace consolidation of the left lower lobe and bilateral infiltrates (*Figure 1*).

 

![Computed tomography of the chest one day after admission to the intensive care unit showing bilateral infiltrates and airspace consolidation of the left lower lobe.](hlv-06-114-g001){#F001}

 

A transthoracic echocardiography excluded a left ventricular dysfunction, and mitral and aortic valves appeared normal. A bronchoalveolar lavage sample showed a neutrophil predominance (\>50%). Despite regression of the inflammatory parameters (CRP from 350 to 129 mg/L and procalcitonin from 6.3 to 2.2 µg/L in three days) high fever persisted with abundant tracheal secretion requiring frequent aspirations and therefore we replaced clarithromycin with intravenous levofloxacin (500 mg/12 h).

The bronchial sample obtained on the day of intubation was cultured on buffered charcoal-yeast extract agar medium on which Legionella longbeachae surprisingly grew. Cultures for other bacteria (including mycobacteria) respiratory viruses and fungi remained negative.

These results allowed us to make a definitive diagnosis of *L. longbeachae* community-acquired pneumonia (CAP) complicated by acute respiratory distress syndrome with septic shock. The clinical course was characterized by a progressive improvement until the sixth day after admission to the ICU. Thereafter, we observed a new worsening of the respiratory parameters without an apparent cause requiring higher FIO~2~ and PEEP levels. In the absence of clinical signs of ventilator associated pneumonia (VAP) further bronchial samples were not obtained and antibiotic coverage remained unchanged. Despite higher FIO~2~ and PEEP levels the patient remained hypoxemic and, to protect the right ventricle from high intrathoracic pressure and to maintain an open-lung ventilation protective strategy (tidal volume of 6 ml per kg ideal body weight and peak airway pressure 2O), with a transient moderate permissive hypercapnia we decided to prone the patient with a consistent improvement allowing us to progressively reduce the respiratory support.

On day thirteen after admission to the ICU the patient developed again high fever with worsening respiratory parameters and hemodynamic instability consistent with a suspected impending VAP. After discussion with the family members and in accordance with the patient's wishes, we decided not to perform the diagnostic evaluation of a suspected VAP and to withhold further support and the patient died shortly after. An autopsy was not performed.

Discussion {#s4}
==========

 

The patient described herein with polymyalgia rheumatica represents a sporadic CAP case with ARDS and septic shock due to *L. longbeachae* infection, diagnosed by culture from bronchial secretions. In accordance with the BAL cultures, and sample with a neutrophil predominance excluding an acute eosinophilic pneumonia and a cryptogenic organizing pneumonia, a contamination seems very unlikely \[[@R001]\]. The delay between the onset of the symptoms and appropriate antibiotic coverage is probably responsible for the development of the ARDS diagnosed in accordance with the Berlin definition \[[@R002]\]. By admission to our ICU the patient presented criteria for early prone positioning \[[@R003]\]. Under standard of care supine low tidal volume ventilation the patient progressively improved rendering prone ventilation initially no more indicated.

The only risk factor for Legionella pneumonia that we could identify was the long-term systemic steroids treatment (10 mg daily of prednisone) associated with depression of-cell mediated immunity. The four days transient increase of prednisone dosage in order to prevent adrenal insufficiency seems unlikely to be responsible for the poor patient's outcome. To the best of our knowledge this case represents the first report of a *L. longbeachae* CAP complicated by ARDS with septic shock in a patient with corticosteroid-dependent polymyalgia rheumatica. Furthermore, this is the first description of a *L. longbeachae* infection in Switzerland.

*L. longbeachae* was first described as a cause of pneumonia in two Californian patients \[[@R004]\]. This infection is very uncommon in the United States and Europe \[[@R005]\] but it accounts for approximately 50% of all cases of Legionnaires' disease in Australia and New Zealand \[[@R006]\], and it is far more prevalent than *L. pneumophila* in Southeast Asia \[[@R007]\].

*L. longbeachae* is one of the soil-dwelling pathogenetic Legionella species and its transmission has been linked to gardening and exposure to potting soil \[[@R008]\]. The present case was notified to the Regional Public Health authorities, but because it was a sporadic case of non-pneumophila Legionella infection, no additional epidemiological investigations were undertaken.

*L. longbeachae* is not only less prevalent than *L. pneumophila* but also probably less virulent \[[@R009]\]. This could be an explanation of its nearly exclusive occurrence in immunosuppressed hosts.

Pneumonia cases due to *L. longbeachae* reported from outside Australia occurred in immunocompromized patients: those undergone splenectomy, under immunosuppressive drugs for systemic lupus erythematosus (SLE) or in transplant recipients \[[@R010]\]. Garcia and coll. reported a fatal case of community-acquired pneumonia due to *L. longbeachae*in Spain \[[@R011]\]. Their young patient with SLE was also under corticosteroid treatment, but in contrast to our patient she had one important additional risk factor for Legionella pneumonia: cigarettes smoking \[[@R012]\]. Moreover despite severe hypoxemia this patient did not fulfill all the criteria for ARDS diagnosis because hydrostatic pulmonary edema was formally not excluded (eg echocardiography).

The widespread introduction of Legionella urinary antigen testing into many hospital laboratories has resulted in a decreasing use of cultures and serology studies \[[@R013]\]. Although urinary antigen test remains positive even during administration of empiric anti-Legionella antibiotics, it is helpful in patients with unproductive cough and the test-result is usually available within hours permitting an early diagnosis, it is only specific for *L. pneumophila* serogroup 1 \[[@R014],[@R015]\]. Therefore it is likely that many infections caused by non-pneumophila species remain undiagnosed, as in our patient at hospital admission. *Legionella* spp. does not grow on blood agar media, and are usually not detected by sputum Gram stain or blood culture.

The standard media for *Legionella* isolation is buffered charcoal-yeast extract agar (BCYE) eventually supplemented with anisomycin, dyes, polymycin and vancomycin to reduce sample contamination. Our findings support the importance of examining sputum for *Legionella* spp. by cultural methods when pneumonia is suspected, especially in the immunocompromized host, where early recognition of the responsible pathogen and appropriate antibiotic therapy are crucial for the patient's survival \[[@R016]\].

Furthermore, the sensitivity of *Legionella* urinary antigen test depends on clinical severity of pneumonia, so that a mild pneumonia or an early-onset pneumonia may go undiagnosed if the test is used alone \[[@R014],[@R015]\].

In summary, this culture-proven case of *L. longbeachae* infection demonstrates that non-pneumophila *Legionella* species must be considered as casual agents of pneumonia even in mild immunosuppressed patients. It should be noted that non-pneumophila *Legionella* infections are probably underreported because urinary antigen testing and serology fail to detect these pathogens and because sputum culture on appropriate media is not always standard practice in the CAP diagnosis.

 A delay in diagnosis and in appropriate antibiotic treatment could significantly affect patients' outcome, especially in the immunocompromized hosts.

Since sputum cultures take several days, empiric anti-Legionella antibiotic coverage and real-time PCR testing should be considered in high-risk patients. Finally, we suggest to administer anti-Legionella antibiotics in severe CAPs if the urinary antigen test is negative, unless another pathogen has been detected as the causal agent and the involvement of *Legionella*has*,* definitively, been ruled out.
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